Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jun 18, 2009


Massachusetts Institute of Technology researcher and Alnylam Pharmaceuticals co-founder Phillip Sharp has been named chair of the Cancer Prevention and Research Institute of Texas' scientific review council, which oversees the selection of the agency's research grants.

CPRIT was established in 2007 to issue $3 billion over 10 years to fund grants for cancer research and prevention.

Opko Health has named Jamie Freedman as vice president of research and development and business development.

Freedman was previously CEO of Locus Pharmaceuticals. Before that, he held various positions at Merck Research Labs. He has an MD and PhD from Tufts University.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.